1206641-31-7 Usage
Uses
Used in Organic Synthesis:
1-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclopropanecarbonitrile is used as a synthetic intermediate for the preparation of various organic compounds. Its boron-containing aromatic ring facilitates cross-coupling reactions, which are essential for the formation of carbon-carbon bonds in the synthesis of complex organic molecules.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 1-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclopropanecarbonitrile is used as a key building block in the synthesis of potential drug candidates. Its unique structure can be incorporated into molecules with specific biological activities, contributing to the discovery of new therapeutic agents.
Used in Material Science:
1-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclopropanecarbonitrile is utilized in the development of novel materials with tailored properties. Its incorporation into polymers or other materials can lead to new materials with improved characteristics, such as enhanced stability, reactivity, or selectivity in various applications.
Used in Chemical Research:
In the field of chemical research, 1-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclopropanecarbonitrile serves as a model compound for studying reaction mechanisms and exploring new synthetic methodologies. Its reactivity and structural features provide a platform for understanding fundamental chemical processes and developing innovative approaches in organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1206641-31-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,6,6,4 and 1 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1206641-31:
(9*1)+(8*2)+(7*0)+(6*6)+(5*6)+(4*4)+(3*1)+(2*3)+(1*1)=117
117 % 10 = 7
So 1206641-31-7 is a valid CAS Registry Number.
1206641-31-7Relevant academic research and scientific papers
[1, 2, 4] TRIAZOLO [1, 5-A] PYRIDINES AS JAK INHIBITORS
-
Page/Page column 62; 63; 94, (2010/04/03)
Novel [1,2,4]triazolo[1,5-a]pyridine compounds are disclosed that have a Formula represented by the following: (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, joint disease, inflammation, and others.
POLYCYCLIC ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS
-
Page/Page column 67, (2010/12/29)
Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.
